AN UNBIASED VIEW OF LDN-27219 AS A CANCER DRUG CANDIDATE

In distinction to neurodegerative illnesses and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has become rather perfectly recognized. The deamidation of precise glutamine residues specific by TG2 in gluten peptides has long been revealed to improve peptide binding into the condition-affiliated proteins HLA-DQ2/8, that happen